ArticleDiscover oncology2025

KYNU is a potential metabolic-related biomarker for nasopharyngeal carcinoma by Raman spectroscopy, metabolomics, and transcriptomics analysis.

Ziman Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.